Key Milestone Achieved: Regulatory Approval in Ghana and Kenya 

November 21, 2017  

BALTIMORE, Maryland, 21 November, 2017 — Exactly one month after we received our regulatory approval in Kenya, we received our regulatory approval in Ghana. These regulatory approvals are a testament to Hemafuse and the hard and diligent work of our team.

With two regulatory approvals, we now have the opportunity to secure purchase orders in two key markets. Ghana is the launching point for the West African market while Kenya is the launching point for the East African market. Once we secure our next round of funding we will be well positioned to enter these two markets and then scale rapidly

WINNERS OF $250K SAVING LIVES AT BIRTH GRANT
We are proud to be the an awardee for the Saving Lives at Birth Validation Grant. This is the second stage of a grant we had been awarded 3 years ago and will fund a multi-country evaluation of Hemafuse. We will also hear in the next couple of months if we qualify for additional funds in addition to the $250k award so keep your ears tuned for even better news!

Sisu was one of just 15 submissions selected out of 550 applicants from around the globe for the prestigious grant from the U.S. Agency for International Development (USAID), the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the Government of Canada), the Norwegian Agency for Development Cooperation (Norad), the U.K’s Department for International Development (DFID) and the Korea International Cooperation Agency (KOICA). 

About Sisu Global: Sisu Global is a corporation headquartered in Baltimore, Maryland. We envision a world where medical technology enables access to healthcare in every community. Right now, 80% of the world’s medical devices are designed for 10% of the world’s population. Sisu aims to change this statistic by designing and scaling medical devices made specifically for the global market. Sisu is the manufacturer of goods including the HEMAFUSE™ System. The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.

Sisu Global’s work has received numerous features such as CBS 60 Minutes, USA Today, Smithsonian.com and awards from GE Healthcare, USAID, the Gates Foundation, and many others. Sisu has presented at scientific and international conferences across the globe.  For more information, please visit our website, https://sisuglobal.health

About HEMAFUSE™: The HEMAFUSE™ is a handheld, mechanical medical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations.  The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.